anakinra

Kineret

Pharmacologic class: Interleukin-1 (IL-1) blocker

Therapeutic class: Immunomodulator, antirheumatic

Pregnancy risk category B

Action

Inhibits binding of IL-1 with IL type I receptors, thereby mediating immunologic, inflammatory, and other physiologic responses

Availability

Prefilled glass syringes: 100 mg/0.67 ml

Indications and dosages

➣ Moderately to severely active rheumatoid arthritis in patients ages 18 and older who don't respond to disease-modifying antirheumatics alone

Adults: 100 mg/day subcutaneously, given at same time each day

Contraindications

• Hypersensitivity to drug or Escherichia coli-derived protein

• Serious infections

Precautions

Use cautiously in:

• immunosuppression, active infection, chronic illness, renal impairment

• elderly patients

• pregnant or breastfeeding patients

• children.

Administration

See Withhold drug and notify prescriber if patient shows signs or symptoms of active infection.

See Use extreme caution if patient is concurrently receiving drugs that block tumor necrosis factor (TNF), because of increased risk of serious infection.

• Give entire dose from prefilled syringe.

• Don't freeze or shake syringe.

Adverse reactions

CNS: headache

EENT: sinusitis

GI: nausea, diarrhea, abdominal pain

Hematologic: thrombocytopenia, neutropenia

Respiratory: upper respiratory tract infection

Skin: rash, pruritus, injection site reaction or bruising, rash, erythema, inflammation

Other: flulike symptoms, infections

Interactions

Drug-drug. Etanercept, infliximab, other drugs that block TNF: increased risk of serious infection

Live-virus vaccines: vaccine inefficacy

Drug-diagnostic tests. Neutrophils: decreased count

Patient monitoring

• Monitor CBC with white cell differential.

• Assess injection site for reactions.

Patient teaching

See Tell patient to immediately report signs or symptoms of infection.

• Advise patient to report signs and symptoms of allergic response.

• Instruct patient to take drug at same time each day for best response.

• Teach patient about proper drug disposal (in puncture-resistant container). Also caution him against reusing needles, syringes, and drug product.

• Tell patient not to freeze or shake drug.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above.

anakinra

A human INTERLEUKIN-1-receptor antagonist used to combat the pro-inflammatory interleukins in RHEUMATOID ARTHRITIS. A brand name is Kineret.

单词	anakinra
释义	anakinra anakinra Kineret *Pharmacologic class:* Interleukin-1 (IL-1) blocker *Therapeutic class:* Immunomodulator, antirheumatic *Pregnancy risk category B* Action Inhibits binding of IL-1 with IL type I receptors, thereby mediating immunologic, inflammatory, and other physiologic responses Availability Prefilled glass syringes: 100 mg/0.67 ml Indications and dosages ➣ Moderately to severely active rheumatoid arthritis in patients ages 18 and older who don't respond to disease-modifying antirheumatics alone Adults: 100 mg/day subcutaneously, given at same time each day Contraindications • Hypersensitivity to drug or Escherichia coli-derived protein • Serious infections Precautions Use cautiously in: • immunosuppression, active infection, chronic illness, renal impairment • elderly patients • pregnant or breastfeeding patients • children. Administration See Withhold drug and notify prescriber if patient shows signs or symptoms of active infection. See Use extreme caution if patient is concurrently receiving drugs that block tumor necrosis factor (TNF), because of increased risk of serious infection. • Give entire dose from prefilled syringe. • Don't freeze or shake syringe. Adverse reactions CNS: headache EENT: sinusitis GI: nausea, diarrhea, abdominal pain Hematologic: thrombocytopenia, neutropenia Respiratory: upper respiratory tract infection Skin: rash, pruritus, injection site reaction or bruising, rash, erythema, inflammation Other: flulike symptoms, infections Interactions Drug-drug. Etanercept, infliximab, other drugs that block TNF: increased risk of serious infection Live-virus vaccines: vaccine inefficacy Drug-diagnostic tests. Neutrophils: decreased count Patient monitoring • Monitor CBC with white cell differential. • Assess injection site for reactions. Patient teaching See Tell patient to immediately report signs or symptoms of infection. • Advise patient to report signs and symptoms of allergic response. • Instruct patient to take drug at same time each day for best response. • Teach patient about proper drug disposal (in puncture-resistant container). Also caution him against reusing needles, syringes, and drug product. • Tell patient not to freeze or shake drug. • As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs and tests mentioned above. anakinra A human INTERLEUKIN-1-receptor antagonist used to combat the pro-inflammatory interleukins in RHEUMATOID ARTHRITIS. A brand name is Kineret.
随便看	national child measurement programme national child minding association national childminding association national child mortality database national child passenger safety awareness national child protection act of 1993 national child protection training center national children and youth fitness study national children's advocacy center national children's alliance national children's bureau national children's cancer society national children’s study national child safety council national child transport association national child traumatic stress initiative national child traumatic stress network national child welfare resource center for adoption national child welfare resource center for youth development national chimney sweep guild national chi nan university national chinese kenpo karate association national chiropractic health care advisory committee national cholesterol education program national cholesterol education program adult treatment panel